Comments
Loading...

Apellis Pharmaceuticals Analyst Ratings

APLSNASDAQ
Logo brought to you by Benzinga Data
$19.27
At close: Jun 11 EDT
$20.22
0.954.94%
Pre-Market: 6:18 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$106.00
Lowest Price Target1
$18.00
Consensus Price Target1
$43.35

Apellis Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:APLS | Benzinga

Apellis Pharmaceuticals Inc has a consensus price target of $43.35 based on the ratings of 21 analysts. The high is $106 issued by Raymond James on January 11, 2024. The low is $18 issued by RBC Capital on May 8, 2025. The 3 most-recent analyst ratings were released by Wells Fargo, Citigroup, and Mizuho on June 2, 2025, May 22, 2025, and May 14, 2025, respectively. With an average price target of $30 between Wells Fargo, Citigroup, and Mizuho, there's an implied 48.35% upside for Apellis Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Feb
2
2
Mar
1
Apr
4
3
May
1
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.2
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Wells Fargo
Citigroup
Mizuho
Raymond James
B of A Securities

1calculated from analyst ratings

Analyst Ratings for Apellis Pharmaceuticals

Buy NowGet Alert
06/02/2025Buy Now43.41%Wells Fargo
Derek Archila61%
$26 → $29MaintainsEqual-WeightGet Alert
05/22/2025Buy Now102.75%Citigroup
Yigal Nochomovitz54%
$49 → $41MaintainsBuyGet Alert
05/14/2025Buy Now-1.1%Mizuho
Graig Suvannavejh51%
$30 → $20MaintainsNeutralGet Alert
05/09/2025Buy Now157.14%Raymond James
Ryan Deschner80%
$75 → $52DowngradeStrong Buy → OutperformGet Alert
05/09/2025Buy Now13.74%B of A Securities
Tazeen Ahmad56%
$41 → $23DowngradeBuy → NeutralGet Alert
05/08/2025Buy Now-10.99%RBC Capital
Luca Issi45%
$21 → $18MaintainsSector PerformGet Alert
05/08/2025Buy Now-1.1%Scotiabank
Greg Harrison50%
$28 → $20MaintainsSector PerformGet Alert
05/08/2025Buy Now28.57%Wells Fargo
Derek Archila61%
$30 → $26MaintainsEqual-WeightGet Alert
05/08/2025Buy Now132.42%Baird
Colleen Kusy37%
$55 → $47MaintainsOutperformGet Alert
05/07/2025Buy Now43.41%Needham
Joseph Stringer62%
$40 → $29MaintainsBuyGet Alert
04/29/2025Buy Now117.58%Cantor Fitzgerald
Eliana Merle49%
→ $44Initiates → OverweightGet Alert
04/21/2025Buy Now3.85%RBC Capital
Luca Issi45%
$24 → $21MaintainsSector PerformGet Alert
04/02/2025Buy Now53.3%Scotiabank
Greg Harrison50%
$30 → $31MaintainsSector PerformGet Alert
03/04/2025Buy Now167.03%JP Morgan
Anupam Rama60%
$50 → $54MaintainsOverweightGet Alert
03/03/2025Buy Now23.63%RBC Capital
Luca Issi45%
$26 → $25MaintainsSector PerformGet Alert
03/03/2025Buy Now58.24%Goldman Sachs
Salveen Richter53%
$36 → $32MaintainsNeutralGet Alert
03/03/2025Buy Now43.41%Wedbush
Laura Chico51%
$30 → $29MaintainsNeutralGet Alert
03/03/2025Buy Now181.87%HC Wainwright & Co.
Douglas Tsao54%
$57 → $57ReiteratesBuy → BuyGet Alert
02/13/2025Buy Now181.87%HC Wainwright & Co.
Douglas Tsao54%
$57 → $57ReiteratesBuy → BuyGet Alert
01/29/2025Buy Now28.57%RBC Capital
Luca Issi45%
$26 → $26MaintainsSector PerformGet Alert
01/21/2025Buy Now28.57%RBC Capital
Luca Issi45%
$26 → $26ReiteratesSector Perform → Sector PerformGet Alert
01/14/2025Buy Now181.87%HC Wainwright & Co.
Douglas Tsao54%
$57 → $57ReiteratesBuy → BuyGet Alert
12/17/2024Buy Now78.02%Goldman Sachs
Salveen Richter53%
→ $36DowngradeBuy → NeutralGet Alert
11/21/2024Buy Now53.3%Morgan Stanley
Judah Frommer64%
→ $31Initiates → Equal-WeightGet Alert
11/07/2024Buy Now171.98%Baird
Colleen Kusy37%
$92 → $55MaintainsOutperformGet Alert
11/06/2024Buy Now152.2%Citigroup
Yigal Nochomovitz54%
$63 → $51MaintainsBuyGet Alert
11/06/2024Buy Now78.02%Goldman Sachs
Salveen Richter53%
$71 → $36MaintainsBuyGet Alert
11/06/2024Buy Now18.68%RBC Capital
Luca Issi45%
$25 → $24MaintainsSector PerformGet Alert
11/06/2024Buy Now48.35%Scotiabank
Greg Harrison50%
$35 → $30MaintainsSector PerformGet Alert
11/06/2024Buy Now48.35%Wells Fargo
Derek Archila61%
$43 → $30MaintainsEqual-WeightGet Alert
11/06/2024Buy Now97.8%Oppenheimer
Justin Kim37%
$65 → $40MaintainsOutperformGet Alert
11/06/2024Buy Now58.24%Piper Sandler
Biren Amin42%
$40 → $32MaintainsNeutralGet Alert
11/06/2024Buy Now181.87%HC Wainwright & Co.
Douglas Tsao54%
$83 → $57MaintainsBuyGet Alert
11/06/2024Buy Now132.42%B of A Securities
Tazeen Ahmad56%
$61 → $47MaintainsBuyGet Alert
11/06/2024Buy Now196.71%Needham
Joseph Stringer62%
$85 → $60MaintainsBuyGet Alert
11/04/2024Buy Now23.63%RBC Capital
Luca Issi45%
$25 → $25ReiteratesSector Perform → Sector PerformGet Alert
10/24/2024Buy Now87.91%Mizuho
Graig Suvannavejh51%
$39 → $38MaintainsNeutralGet Alert
10/16/2024Buy Now73.08%Scotiabank
Greg Harrison50%
→ $35Initiates → Sector PerformGet Alert
10/16/2024Buy NowWilliam Blair
Lachlan Brown38%
Initiates → OutperformGet Alert
09/24/2024Buy Now112.64%Wells Fargo
Derek Archila61%
$47 → $43MaintainsEqual-WeightGet Alert
09/23/2024Buy Now354.95%Baird
Colleen Kusy37%
$96 → $92MaintainsOutperformGet Alert
09/20/2024Buy Now92.86%Mizuho
Graig Suvannavejh51%
$42 → $39MaintainsNeutralGet Alert
09/20/2024Buy Now320.33%Needham
Joseph Stringer62%
$85 → $85ReiteratesBuy → BuyGet Alert
09/13/2024Buy Now181.87%JP Morgan
Anupam Rama60%
$64 → $57MaintainsOverweightGet Alert
08/13/2024Buy Now216.49%JP Morgan
Anupam Rama60%
$72 → $64MaintainsOverweightGet Alert
08/09/2024Buy Now310.44%UBS
Eliana Merle49%
$85 → $83MaintainsBuyGet Alert
08/09/2024Buy Now102.75%Wedbush
Laura Chico51%
$38 → $41MaintainsNeutralGet Alert
08/09/2024Buy Now265.94%Goldman Sachs
Salveen Richter53%
$66 → $74MaintainsBuyGet Alert
08/09/2024Buy Now374.73%Baird
Colleen Kusy37%
$86 → $96MaintainsOutperformGet Alert
08/09/2024Buy Now320.33%Needham
Joseph Stringer62%
$85 → $85ReiteratesBuy → BuyGet Alert
08/02/2024Buy Now310.44%HC Wainwright & Co.
Douglas Tsao54%
$92 → $83MaintainsBuyGet Alert
08/02/2024Buy Now226.38%Goldman Sachs
Salveen Richter53%
$77 → $66MaintainsBuyGet Alert
08/02/2024Buy Now320.33%Needham
Joseph Stringer62%
$85 → $85ReiteratesBuy → BuyGet Alert
07/31/2024Buy Now295.61%Jefferies
Akash Tewari42%
$80 → $80MaintainsBuyGet Alert
07/26/2024Buy Now325.28%Baird
Colleen Kusy37%
$100 → $86MaintainsOutperformGet Alert
07/23/2024Buy Now394.51%Baird
Colleen Kusy37%
$100 → $100MaintainsOutperformGet Alert
07/17/2024Buy Now280.77%Goldman Sachs
Salveen Richter53%
$90 → $77MaintainsBuyGet Alert
06/28/2024Buy Now394.51%Baird
Colleen Kusy37%
$100 → $100MaintainsOutperformGet Alert
05/31/2024Buy Now127.47%Piper Sandler
Biren Amin42%
→ $46Initiates → NeutralGet Alert
05/28/2024Buy Now354.95%HC Wainwright & Co.
Douglas Tsao54%
$92 → $92ReiteratesBuy → BuyGet Alert
05/23/2024Buy Now137.36%Wells Fargo
Derek Archila61%
$57 → $48MaintainsEqual-WeightGet Alert
05/08/2024Buy Now320.33%Needham
Joseph Stringer62%
$85 → $85ReiteratesBuy → BuyGet Alert
05/08/2024Buy Now196.71%Citigroup
Yigal Nochomovitz54%
$67 → $60MaintainsBuyGet Alert
05/08/2024Buy Now354.95%HC Wainwright & Co.
Douglas Tsao54%
→ $92ReiteratesBuy → BuyGet Alert
05/08/2024Buy Now320.33%UBS
Eliana Merle49%
$89 → $85MaintainsBuyGet Alert
04/29/2024Buy Now157.14%Mizuho
Graig Suvannavejh51%
$60 → $52MaintainsNeutralGet Alert
04/26/2024Buy Now354.95%HC Wainwright & Co.
Douglas Tsao54%
$92 → $92ReiteratesBuy → BuyGet Alert
04/25/2024Buy Now320.33%Needham
Joseph Stringer62%
$85 → $85ReiteratesBuy → BuyGet Alert
04/17/2024Buy Now181.87%Wedbush
Laura Chico51%
$67 → $57MaintainsNeutralGet Alert
04/15/2024Buy Now354.95%HC Wainwright & Co.
Douglas Tsao54%
$92 → $92ReiteratesBuy → BuyGet Alert
04/09/2024Buy Now320.33%Needham
Joseph Stringer62%
$85 → $85ReiteratesBuy → BuyGet Alert
03/27/2024Buy Now196.71%Mizuho
Graig Suvannavejh51%
$60 → $60MaintainsNeutralGet Alert
03/06/2024Buy Now290.66%JP Morgan
Anupam Rama60%
$78 → $79MaintainsOverweightGet Alert
03/04/2024Buy Now340.11%UBS
Eliana Merle49%
$87 → $89MaintainsBuyGet Alert
02/28/2024Buy Now354.95%HC Wainwright & Co.
Douglas Tsao54%
$92 → $92ReiteratesBuy → BuyGet Alert
02/28/2024Buy Now231.32%Wedbush
Laura Chico51%
$60 → $67MaintainsNeutralGet Alert
02/16/2024Buy Now196.71%Mizuho
Graig Suvannavejh51%
$49 → $60MaintainsNeutralGet Alert
02/06/2024Buy Now300.55%Baird
Colleen Kusy37%
→ $81ReiteratesOutperform → OutperformGet Alert
02/05/2024Buy Now295.61%Jefferies
Akash Tewari42%
$68 → $80UpgradeHold → BuyGet Alert
01/30/2024Buy Now290.66%Oppenheimer
Justin Kim37%
$75 → $79MaintainsOutperformGet Alert
01/24/2024Buy Now270.88%Needham
Joseph Stringer62%
$70 → $75MaintainsBuyGet Alert
01/17/2024Buy Now300.55%Baird
Colleen Kusy37%
$71 → $81MaintainsOutperformGet Alert
01/17/2024Buy Now354.95%HC Wainwright & Co.
Douglas Tsao54%
$82 → $92MaintainsBuyGet Alert
01/12/2024Buy Now196.71%Wedbush
Laura Chico51%
$39 → $60MaintainsNeutralGet Alert
01/11/2024Buy Now424.18%Raymond James
Steven Seedhouse58%
$67 → $106MaintainsStrong BuyGet Alert
01/09/2024Buy Now345.06%Goldman Sachs
Salveen Richter53%
$65 → $90MaintainsBuyGet Alert
12/15/2023Buy Now231.32%Citigroup
Yigal Nochomovitz54%
$70 → $67MaintainsBuyGet Alert
12/15/2023Buy Now270.88%Oppenheimer
Justin Kim37%
$88 → $75MaintainsOutperformGet Alert
12/15/2023Buy Now231.32%Raymond James
Steven Seedhouse58%
$93 → $67MaintainsStrong BuyGet Alert
12/14/2023Buy Now176.92%Needham
Joseph Stringer62%
$63 → $56MaintainsBuyGet Alert
12/14/2023Buy Now167.03%Wells Fargo
Derek Archila61%
$67 → $54DowngradeOverweight → Equal-WeightGet Alert
12/05/2023Buy Now320.33%B of A Securities
Tazeen Ahmad56%
$52 → $85UpgradeNeutral → BuyGet Alert
11/09/2023Buy Now265.94%Goldman Sachs
Salveen Richter53%
→ $74Initiates → BuyGet Alert
11/02/2023Buy Now107.69%Mizuho
Graig Suvannavejh51%
→ $42Initiates → NeutralGet Alert
11/02/2023Buy Now359.89%Raymond James
Steven Seedhouse58%
$92 → $93MaintainsStrong BuyGet Alert
11/01/2023Buy Now211.54%Needham
Joseph Stringer62%
$60 → $63MaintainsBuyGet Alert
10/12/2023Buy Now127.47%B of A Securities
Tazeen Ahmad56%
$44 → $46MaintainsNeutralGet Alert
10/06/2023Buy Now246.16%Citigroup
Yigal Nochomovitz54%
$54 → $70MaintainsBuyGet Alert
10/06/2023Buy Now300.55%JP Morgan
Anupam Rama60%
$60 → $81UpgradeNeutral → OverweightGet Alert
10/06/2023Buy Now354.95%Raymond James
Steven Seedhouse58%
$89 → $92MaintainsStrong BuyGet Alert

FAQ

Q

What is the target price for Apellis Pharmaceuticals (APLS) stock?

A

The latest price target for Apellis Pharmaceuticals (NASDAQ:APLS) was reported by Wells Fargo on June 2, 2025. The analyst firm set a price target for $29.00 expecting APLS to rise to within 12 months (a possible 43.41% upside). 58 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Apellis Pharmaceuticals (APLS)?

A

The latest analyst rating for Apellis Pharmaceuticals (NASDAQ:APLS) was provided by Wells Fargo, and Apellis Pharmaceuticals maintained their equal-weight rating.

Q

When was the last upgrade for Apellis Pharmaceuticals (APLS)?

A

The last upgrade for Apellis Pharmaceuticals Inc happened on February 5, 2024 when Jefferies raised their price target to $80. Jefferies previously had a hold for Apellis Pharmaceuticals Inc.

Q

When was the last downgrade for Apellis Pharmaceuticals (APLS)?

A

The last downgrade for Apellis Pharmaceuticals Inc happened on May 9, 2025 when Raymond James changed their price target from $75 to $52 for Apellis Pharmaceuticals Inc.

Q

When is the next analyst rating going to be posted or updated for Apellis Pharmaceuticals (APLS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Apellis Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Apellis Pharmaceuticals was filed on June 2, 2025 so you should expect the next rating to be made available sometime around June 2, 2026.

Q

Is the Analyst Rating Apellis Pharmaceuticals (APLS) correct?

A

While ratings are subjective and will change, the latest Apellis Pharmaceuticals (APLS) rating was a maintained with a price target of $26.00 to $29.00. The current price Apellis Pharmaceuticals (APLS) is trading at is $20.22, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch